Kashiv BioSciences Secures $77 Million Financing to Build India's Largest Single-Use Biologics Manufacturing Facility
核心洞察
Kashiv BioSciences (搜索) has secured INR 648 crore ($77 million) financing from Union Bank of India (搜索) to expand its state-of-the-art manufacturing facility in Pipan, Gujarat.
The new single-use commercial manufacturing facility will be one of India's largest, equipped with cutting-edge technologies and capable of producing up to 50,000L at full capacity.
The facility will serve customers across the U.S., Canada, Europe, and other international markets, reinforcing India's role as the "pharmacy of the world."
Kashiv BioSciences (搜索) Private Limited has secured INR 648 crore ($77 million) in financing from Union Bank of India (搜索) to expand its state-of-the-art manufacturing facility in Pipan, near Ahmedabad, Gujarat. The investment represents one of the largest commitments to biologics (搜索) manufacturing infrastructure in India and positions the company to significantly expand its global production capabilities.
Facility Specifications and Capacity
The new single-use commercial manufacturing facility will be one of India's largest, equipped with cutting-edge technologies to support the production of high-quality biologics (搜索) and specialty pharmaceuticals. At full capacity, Kashiv expects the facility to manufacture up to 50,000L, representing a substantial increase in the company's production capabilities.
The facility will utilize advanced single-use technology, which offers greater flexibility and efficiency in biologics (搜索) manufacturing compared to traditional stainless-steel systems. This approach allows for faster changeovers between products and reduced contamination risks, critical factors in the production of complex biological medicines.
Global Market Reach and Strategic Impact
The expanded facility will serve customers across the U.S., Canada, Europe, and other international markets, further reinforcing India's role as the "pharmacy of the world." The investment is expected to enhance technical capabilities, improve global competitiveness, and create long-term, high-value employment across scientific, technical, and operational disciplines.
"This funding marks a pivotal milestone in Kashiv's journey to expand biomanufacturing capacity in India," said Dr. Sandeep Athalye, Global CEO of Kashiv BioSciences (搜索). "The new facility in Pipan will not only accelerate innovation and access to high-quality biologics (搜索) but also reinforce our commitment to building world-class infrastructure that supports global healthcare needs."
Government Support and Policy Alignment
The infrastructure development is being financed with support from Union Bank of India (搜索) and aligns with the Biotechnology Policy and schemes implemented by GSBTM (Gujarat State Biotechnology Mission (搜索)), a body of the state government that continues to catalyze investment in advanced biopharmaceutical manufacturing.
Shri Digvijaysinh D. Jadeja, IAS, Mission Director of the GSBTM, emphasized the project's significance: "Kashiv's expansion in Pipan exemplifies Gujarat's commitment to fostering innovation-led growth in biotechnology. Through the Biotechnology Policy, we continue to support high-impact investments that elevate India's scientific capabilities and create meaningful employment across the value chain."
Company Background and Capabilities
Kashiv BioSciences (搜索) Private Limited, a fully owned subsidiary of Kashiv BioSciences, LLC, is a biopharmaceutical company with numerous commercial and advanced clinical-stage assets. The company is among the few to both manufacture and receive marketing authorization for multiple biosimilars, positioning it uniquely in the competitive biologics (搜索) landscape.
The company operates with robust infrastructure and highly skilled teams that provide global R&D, clinical, manufacturing, regulatory, and intellectual property capabilities across its operations in the USA and India.
A senior representative from Union Bank of India (搜索) expressed support for the initiative: "Union Bank is proud to have partnered with Kashiv as the lender on this initiative. This will advance India's manufacturing capabilities and create sustainable economic value for the region, supporting the nation in achieving its goal of 'Viksit and Atmanirbhar Bharat'."